Clinical Trials Directory

Trials / Completed

CompletedNCT01258699

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Bukwang Pharmaceutical · Industry
Sex
Male
Age
20 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study is Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjects.

Conditions

Interventions

TypeNameDescription
DRUGThiocacid HR Tab 600mg600mg for 1 day
DRUGBK-C-0701 320mg320mg for 1 day
DRUGBK-C-0701 480mg480mg for 1 day

Timeline

Start date
2009-08-01
First posted
2010-12-13
Last updated
2010-12-13

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01258699. Inclusion in this directory is not an endorsement.

A Study Comparing the Pharmacokinetics of BK-C-0701 320mg, 480mg and Thiocacid HR Tab 600mg in Healthy Adult Male Subjec (NCT01258699) · Clinical Trials Directory